Nothing should be bought from China
Canada’s first big push for a COVID-19 vaccine may be falling victim to sour relations with Beijing, as Chinese officials continue to hold up a shipment of the drug needed to carry out promised human trials here.
CanSino Biologics of Tianjin, China signed an accord with the federal government in May to have its vaccine tested in Canada, a heavily promoted deal the government said could give Canadians early access to the serum.
But more two-and-a-half months later, the Canadian trials have yet to start, because scientists have nothing to study.
Samples of the vaccine candidate – already one of the world’s most advanced in terms of the trial process – have not been approved for shipment to Canada by Chinese customs, one of the researchers confirmed Tuesday.
David Mulroney, Canada’s ambassador to China from 2009 to 2012, said it’s hard to know why the delivery has been stalled, but he has his suspicions.
“It’s likely that the shipment is being delayed as part of China’s retaliation against Canada over the Meng (Wanzhou) arrest,” he said, referring to the Huawei Technologies CFO held in Vancouver on a U.S. extradition request.
“But it could also be due to the kind of sudden, unexplained delay that routinely happens when you’re dealing with China’s opaque and often uncooperative customs authorities,” Mulroney added. “Either way, it raises the question of why the NRC thought it was a good idea to work with a Chinese partner on such a sensitive project.”
Canada’s first big push for a COVID-19 vaccine may be falling victim to sour relations with Beijing, as Chinese officials continue to hold up a shipment of the drug needed to carry out promised human trials here.
CanSino Biologics of Tianjin, China signed an accord with the federal government in May to have its vaccine tested in Canada, a heavily promoted deal the government said could give Canadians early access to the serum.
But more two-and-a-half months later, the Canadian trials have yet to start, because scientists have nothing to study.
Samples of the vaccine candidate – already one of the world’s most advanced in terms of the trial process – have not been approved for shipment to Canada by Chinese customs, one of the researchers confirmed Tuesday.
David Mulroney, Canada’s ambassador to China from 2009 to 2012, said it’s hard to know why the delivery has been stalled, but he has his suspicions.
“It’s likely that the shipment is being delayed as part of China’s retaliation against Canada over the Meng (Wanzhou) arrest,” he said, referring to the Huawei Technologies CFO held in Vancouver on a U.S. extradition request.
“But it could also be due to the kind of sudden, unexplained delay that routinely happens when you’re dealing with China’s opaque and often uncooperative customs authorities,” Mulroney added. “Either way, it raises the question of why the NRC thought it was a good idea to work with a Chinese partner on such a sensitive project.”
China spat may be threatening Canada's bid to get early access to leading COVID-19 vaccine: experts
Samples of the vaccine candidate have not been approved for shipment to Canada by Chinese customs, one of the researchers confirmed Tuesday
nationalpost.com